鲁抗医药：关于拟竞购山东鲁抗和成制药有限公司股权的公告

Group 1 - The core point of the article is that LuKang Pharmaceutical announced its intention to acquire a 1.9231% stake in Shandong LuKang Hecheng Pharmaceutical Co., Ltd. through a bidding process at the Shandong Property Rights Exchange Center [1] - Upon completion of this transaction, the company will hold 100% of the shares in Hecheng Company, although the scope of the company's consolidated financial statements will remain unchanged [1]